OPN (or secreted phosphoprotein-1) acts via binding to αvβ3 integrin and CD44 and plays a key role in both the metastatic spread as well as the drug-sensitivity of breast and prostate cancer. This evidence concerns the gene SPP1 and prostate cancer.